Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
2017: University of Leeds researchers and Novo Nordisk report that semaglutide can be used to treat obesity
Ready to take the first step toward a lighter, healthier you
Phase 3 enrollment is currently in progress
10.1074/jbc.M809671200 72 KumarP.PadiS
It binds to harmful substances and helps flush them out
Clinical Trial Evidence and Weight Loss Outcomes A Phase 2 RCT (NEJM 2023) reported approximately 24% mean body weight reduction at 48 weeks with the 12 mg dose
US$ 26.20
US$ 29.43
US$ 21.23
